Hisashi Wada

ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 15

Top Venues

British journal of cancer

Cancer immunology, immunotherapy : CII

Nature medicine

Scientific reports

Osaka University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Osaka University Apr 01 2014

Japan

Professor :: Medicine

Publications

Takuro Saito, Yukinori Kurokawa, Kazumasa Fujitani, Ryohei Kawabata, Atsushi Takeno, Jota Mikami, Shunji Endo, Jin Matsuyama, Yusuke Akamaru, Masashi Hirota, Kentaro Kishi, Shinya Urakawa, Kei Yamamoto, Koji Tanaka, Tsuyoshi Takahashi, Mikio Oka, Hisashi Wada, Hidetoshi Eguchi, Yuichiro Doki
Serum NY-ESO-1 antibody as a predictive biomarker for postoperative recurrence of gastric cancer: a multicenter prospective observational study. British journal of cancer 130 (7) (2024)
Takuro Saito, Yukinori Kurokawa, Kazumasa Fujitani, Ryohei Kawabata, Atsushi Takeno, Jota Mikami, Shunji Endo, Jin Matsuyama, Yusuke Akamaru, Masashi Hirota, Kentaro Kishi, Shinya Urakawa, Kei Yamamoto, Koji Tanaka, Tsuyoshi Takahashi, Mikio Oka, Hisashi Wada, Hidetoshi Eguchi, Yuichiro Doki
Serum NY-ESO-1 antibody as a predictive biomarker for postoperative recurrence of gastric cancer: a multicenter prospective observational study. British journal of cancer 130 (7) (2024)
Takuro Saito, Yukinori Kurokawa, Kazumasa Fujitani, Ryohei Kawabata, Atsushi Takeno, Jota Mikami, Shunji Endo, Jin Matsuyama, Yusuke Akamaru, Masashi Hirota, Kentaro Kishi, Shinya Urakawa, Kei Yamamoto, Koji Tanaka, Tsuyoshi Takahashi, Mikio Oka, Hisashi Wada, Hidetoshi Eguchi, Yuichiro Doki
Serum NY-ESO-1 antibody as a predictive biomarker for postoperative recurrence of gastric cancer: a multicenter prospective observational study. British journal of cancer (2024)
Takuro Saito, Yukinori Kurokawa, Kazumasa Fujitani, Ryohei Kawabata, Atsushi Takeno, Jota Mikami, Shunji Endo, Jin Matsuyama, Yusuke Akamaru, Masashi Hirota, Kentaro Kishi, Shinya Urakawa, Kei Yamamoto, Koji Tanaka, Tsuyoshi Takahashi, Mikio Oka, Hisashi Wada, Hidetoshi Eguchi, Yuichiro Doki
Serum NY-ESO-1 antibody as a predictive biomarker for postoperative recurrence of gastric cancer: a multicenter prospective observational study. British journal of cancer 130 (7) (2024)
Takuro Saito, Yukinori Kurokawa, Kazumasa Fujitani, Ryohei Kawabata, Atsushi Takeno, Jota Mikami, Shunji Endo, Jin Matsuyama, Yusuke Akamaru, Masashi Hirota, Kentaro Kishi, Shinya Urakawa, Kei Yamamoto, Koji Tanaka, Tsuyoshi Takahashi, Mikio Oka, Hisashi Wada, Hidetoshi Eguchi, Yuichiro Doki
Serum NY-ESO-1 antibody as a predictive biomarker for postoperative recurrence of gastric cancer: a multicenter prospective observational study. British journal of cancer 130 (7) (2024)
Azumi Ueyama, Wataru Nogami, Kunitaka Nashiki, Miya Haruna, Hiroto Miwa, Masaki Hagiwara, Morio Nagira, Hisashi Wada, Yoji Nagira
Immunotherapy Targeting CCR8+ Regulatory T Cells Induces Antitumor Effects via Dramatic Changes to the Intratumor CD8+ T Cell Profile. Journal of immunology (Baltimore, Md. : 1950) (2023)
Yoshinori Hayashi, Tomoki Makino, Eiichi Sato, Kenji Ohshima, Yuya Nogi, Takashi Kanemura, Keiichiro Honma, Kotaro Yamashita, Takuro Saito, Koji Tanaka, Kazuyoshi Yamamoto, Tsuyoshi Takahashi, Yukinori Kurokawa, Hiroshi Miyata, Kiyokazu Nakajima, Hisashi Wada, Eiichi Morii, Hidetoshi Eguchi, Yuichiro Doki
Density and maturity of peritumoral tertiary lymphoid structures in oesophageal squamous cell carcinoma predicts patient survival and response to immune checkpoint inhibitors. British journal of cancer (2023)
Kaoru Fujikawa, Takuro Saito, Koji Kurose, Takashi Kojima, Takeru Funakoshi, Eiichi Sato, Kazuhiko Kakimi, Shinsuke Iida, Yuichiro Doki, Mikio Oka, Ryuzo Ueda, Hisashi Wada
Integrated analysis of phase 1a and 1b randomized controlled trials; Treg-targeted cancer immunotherapy with the humanized anti-CCR4 antibody, KW-0761, for advanced solid tumors. PloS one 18 (9) (2023)
Yoji Nagira, Morio Nagira, Ryohei Nagai, Wataru Nogami, Michinari Hirata, Azumi Ueyama, Tetsuya Yoshida, Mai Yoshikawa, Satomi Shinonome, Hiroshi Yoshida, Miya Haruna, Hiroto Miwa, Natsumi Chatani, Naganari Ohkura, Hisashi Wada, Hidekazu Tanaka
S-531011, a novel anti-human CCR8 antibody, induces potent anti-tumor responses through depletion of tumor-infiltrating CCR8-expressing regulatory T cells. Molecular cancer therapeutics (2023)
Yuka Maeda, Hisashi Wada, Daisuke Sugiyama, Takuro Saito, Takuma Irie, Kota Itahashi, Kodai Minoura, Susumu Suzuki, Takashi Kojima, Kazuhiko Kakimi, Jun Nakajima, Takeru Funakoshi, Shinsuke Iida, Mikio Oka, Teppei Shimamura, Toshihiko Doi, Yuichiro Doki, Eiichi Nakayama, Ryuzo Ueda, Hiroyoshi Nishikawa
Depletion of central memory CD8 + T cells might impede the antitumor therapeutic effect of Mogamulizumab. Nature communications 12 (1) (2021)
Shinya Urakawa, Makoto Yamasaki, Tomoki Makino, Yukinori Kurokawa, Kei Yamamoto, Kumiko Goto, Miya Haruna, Michinari Hirata, Akiko Morimoto-Okazawa, Atsunari Kawashima, Kota Iwahori, Tsunekazu Mizushima, Eiichi Sato, Masaki Mori, Yuichiro Doki, Hisashi Wada
The impact of ICOS+ regulatory T cells and Helicobacter pylori infection on the prognosis of patients with gastric and colorectal cancer: potential prognostic benefit of pre-operative eradication therapy. Cancer immunology, immunotherapy : CII 70 (2) (2020)
Kota Iwahori, Yasushi Shintani, Soichiro Funaki, Yoko Yamamoto, Mitsunobu Matsumoto, Tetsuya Yoshida, Akiko Morimoto-Okazawa, Atsunari Kawashima, Eiichi Sato, Stephen Gottschalk, Meinoshin Okumura, Atsushi Kumanogoh, Hisashi Wada
Peripheral T cell cytotoxicity predicts T cell function in the tumor microenvironment. Scientific reports 9 (1) (2019)
Shinya Urakawa, Makoto Yamasaki, Kumiko Goto, Miya Haruna, Michinari Hirata, Akiko Morimoto-Okazawa, Atsunari Kawashima, Kota Iwahori, Tomoki Makino, Yukinori Kurokawa, Tomomi Yamada, Masaki Mori, Yuichiro Doki, Hisashi Wada
Peri-operative monocyte count is a marker of poor prognosis in gastric cancer: increased monocytes are a characteristic of myeloid-derived suppressor cells. Cancer immunology, immunotherapy : CII 68 (8) (2019)
Ryo Kato, Makoto Yamasaki, Shinya Urakawa, Kentaro Nishida, Tomoki Makino, Akiko Morimoto-Okazawa, Atsunari Kawashima, Kota Iwahori, Susumu Suzuki, Ryuzo Ueda, Masaki Mori, Taroh Satoh, Yuichiro Doki, Hisashi Wada
Increased Tim-3+ T cells in PBMCs during nivolumab therapy correlate with responses and prognosis of advanced esophageal squamous cell carcinoma patients. Cancer immunology, immunotherapy : CII 67 (11) (2018)
Takuro Saito, Hiroyoshi Nishikawa, Hisashi Wada, Yuji Nagano, Daisuke Sugiyama, Koji Atarashi, Yuka Maeda, Yoshitaka Hashimoto, Naganari Ohkura, Eiichi Sato, Hirotsugu Nagase, Junichi Nishimura, Hirofumi Yamamoto, Shuji Takiguchi, Takeshi Tanoue, Wataru Suda, Hidetoshi Morita, Masahira Hattori, Kenya Honda, Masaki Mori, Yuichiro Doki, Shimon Sakaguchi
Two FOXP3(+)CD4(+) T cell subpopulations distinctly control the prognosis of colorectal cancers. Nature medicine 22 (6) (2016)

Hisashi Wada.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Hisashi Wada